| Company Name: |
Shanghai Boyle Chemical Co., Ltd.
|
| Tel: |
|
| Email: |
sales@boylechem.com |
| Products Intro: |
Product Name: ((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine
CAS:1400898-49-8
|
| Company Name: |
Hefei HomeSunshine Pharmaceutical Technology Co., Ltd.
|
| Tel: |
0551-65523315 17705606359 |
| Email: |
errol@homesunshinepharma.com |
| Products Intro: |
Product Name:((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine
CAS:1400898-49-8
Purity:CP>=99.5%,ee>=99.9% Package:1g, 10g, 100g, 1kg, 5kg Remarks:Single Impurity≤0.1%
|
| Company Name: |
Shanghai Biopharmaleader Co., Ltd.
|
| Tel: |
+86 18721201413 |
| Email: |
sales@biopharmaleader.com |
| Products Intro: |
Product Name:((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine
CAS:1400898-49-8
Purity:98%HPLC Package:10g,100g
|
| Company Name: |
Chengdu Feibai Pharmaceutical Co., Ltd.
|
| Tel: |
028-84641798 18782128315 |
| Email: |
3302391190@qq.com |
| Products Intro: |
Product Name:(1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine
CAS:1400898-49-8
Purity:97 Package:5g;50g;100g;250g;500g;1kg;5kg
|
|
| | ((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine Basic information |
| Product Name: | ((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine | | Synonyms: | ((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine;((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine;((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanami;Cyclopropanemethanamine, 2-(2,3-dihydro-4-benzofuranyl)-, (1R,2R)- | | CAS: | 1400898-49-8 | | MF: | C12H15NO | | MW: | 189.25 | | EINECS: | | | Product Categories: | | | Mol File: | 1400898-49-8.mol |  |
| | ((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine Chemical Properties |
| | ((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine Usage And Synthesis |
| Uses | ((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine is an intermediate int he synthesis of Tasimelteon (T007740), a novel drug, used in the treatment of non-24 hour sleep-wake disorder. It helps to correct the circadian rhythm disorder often seen in patients who are visually impaired. |
| | ((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methanamine Preparation Products And Raw materials |
|